This article discusses the effectiveness of Ivermectin in treating Covid-19 and compares it with other potential therapies.
Ivermectin was considered a wonder drug before the Covid-19 pandemic. It's only after it threatened profits that the campaigning on its efficacy started.
This paper provides an update on the prevention and treatment of Covid-19 with Ivermectin.
This article discusses the prevention and treatment updates using Ivermectin for Covid-19.
This article provides the pharmacokinetic rationale for using Ivermectin in Covid-19 therapy.
This article reviews potential therapies against Covid-19 with a focus on Ivermectin.
Ivermectin was consistently subject to negative campaigning and messaging in the media, a very unusual thing for an otherwise safe and anonymous drug.
This sets up a story of how a crucial paper that informed scientific and policy opinion on the efficacy of Ivermectin against Covid-19 was actually altered by a pharmaceutical lobby
Ivermectin works as a treatment for Covid-19 and was campaigned against by the pharmaceutical industry who instead wanted to sell novel and less effective therapeutics
Key data on Ivermectin was literally altered by people informally working for the pharmaceutical industry. The drug posed a threat to the profits of novel products which those same people were researching and pushing through the regulatory process at the same time.
Edit Your Case
Add Source
cases remaining
You are on the free plan. You can create 5 free cases, with a maximum of 10 sources each. Upgrade to Premium at $10/mo for unlimited cases with up to 1000 sources.